These results support the role of SPL in sphingolipid pathway modulation in mouse colon cancer cell lysates with enhanced or inhibited SPL expression, demonstrating changes in S1P levels and corresponding alterations in other sphingolipids (Supplementary Fig. S4). The gene discussed is SGPL1; the disease is malignant colon neoplasm.